Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Quality & Risk

    Summative vs. Formative Evaluation

    In one line
    Iterative usability studies (formative) vs. final validation testing (summative) of a device's user interface.
    Definition
    Formative evaluations are exploratory tests during design used to identify usability issues. Summative (validation) evaluations occur on the final design with representative users in realistic conditions to demonstrate critical tasks can be performed safely and effectively. Formative work often uses small groups, prototypes and think-aloud methods, and results drive design changes. Summative validation per FDA guidance and IEC 62366-1 typically uses at least 15 participants per distinct user group, tests the final user interface including labeling and training, and focuses on critical tasks. Use errors seen in summative testing must be analyzed for root cause and residual risk.
    Why it matters
    Per FDA HF guidance and IEC 62366-1, summative studies typically include at least 15 users per distinct user group. Findings from summative studies that surface new use errors must be addressed before market.
    Common pitfalls
    • •Confusing formative testing with design verification; formative evaluations are for improvement, not formal verification.
    • •Failing to adequately document formative evaluation findings and subsequent design changes, hindering traceability for regulatory submissions.
    • •Conducting summative evaluations with non-representative users or in unrealistic environments, invalidating the study’s findings.
    • •Underestimating the resources and time required for a robust summative evaluation, leading to rushed or poorly executed studies.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.